Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Updates on Treatment of Esophageal Cancer"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383).
Deadline for manuscript submissions: closed (30 April 2016).
Tel. +1 646 962 6200; Fax: +1 646 962 1607
Interests: drug development; biomarkers; angiogenesis; signal transduction; genetic syndromes; symptom management; comparative effectiveness; immuno-oncology; tumor biology
We are truly entering a new era in the management of upper GI malignancies. There is an emergence of new targeted therapies, including recent-approved drugs that target HER2 and antiangiogenic therapy, as well as exciting preliminary data involving immune checkpoint inhibitors, and other pathways, including PTEN/AKT, stem cell inhibitors, and FGF inhibitors. In parallel to this remarkable growth of targeted options, we have improved our classification of both esophageal and gastric cancers, based on molecular profiling. As a result, we are slowly improving outcomes in these diseases. This Special Issue of the Journal of Clinical Medicine will focus on “Advances in Esophagus Cancer”, including cancers of the gastroesophageal junction. I invite you to submit your article with a special focus on any of the following topics:
- novel pathways in esophageal/GEJ carcinoma
- molecular profiling of esophageal/GEJ carcinoma
- tumor microenvironment
- premalignant conditions and their progression to malignancy
- new drugs and drug targets
- early phase clinical trials
- disease heterogeneity—both tumor and global
- comparative effectiveness research
Prof. Dr. Manish A. Shah
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- PD1, PDL1
- molecular profiling
- phase 1, phase 2
- Barrett’s esophagus
- tumor infiltrating lymphocytes
- tumor microenvironment